APO Research
Talk to an analyst

APO RESEARCH · REPORT

Melanocortin Receptor 4

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Melanocortin Receptor 4 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025189 pages

Choose your research edition.

Industry ResearchMelanocortin Receptor 4 Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Melanocortin Receptor 4 Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Melanocortin Receptor 4 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Melanocortin Receptor 4 Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Melanocortin Receptor 4 Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Melanocortin Receptor 4 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Melanocortin Receptor 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Melanocortin Receptor 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Melanocortin Receptor 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Melanocortin Receptor 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Melanocortin Receptor 4 include Pfizer Inc., AstraZeneca Plc, Rhythm Pharmaceuticals, Inc., Retrophin Inc., Palatin Technologies, Inc., Obexia AG and Mallinckrodt Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Melanocortin Receptor 4 market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Melanocortin Receptor 4 and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Melanocortin Receptor 4 revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Melanocortin Receptor 4 market size, projected growth trends, production technologies, key applications, and end-use industries.

Melanocortin Receptor 4 Segment by Company

Pfizer Inc.

AstraZeneca Plc

Rhythm Pharmaceuticals, Inc.

Retrophin Inc.

Palatin Technologies, Inc.

Obexia AG

Mallinckrodt Plc

Melanocortin Receptor 4 Segment by Type

Cosyntropin

Corticotropin

Bremelanotide

Others

Melanocortin Receptor 4 Segment by Application

Genito Urinary System

Infection Disease

Women's Health

Metabolic Disorder

Others

Melanocortin Receptor 4 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Melanocortin Receptor 4 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Melanocortin Receptor 4 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Melanocortin Receptor 4.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Melanocortin Receptor 4 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Melanocortin Receptor 4 industry.

Chapter 3: Detailed analysis of Melanocortin Receptor 4 companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Melanocortin Receptor 4revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Melanocortin Receptor 4 Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Cosyntropin Table 3. Key Players of Corticotropin Table 4. Key Players of Bremelanotide Table 3. Key Players of Others Table 4. Global Melanocortin Receptor 4 Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Genito Urinary System Table 6. Key Players of Infection Disease Table 7. Key Players of Women's Health Table 8. Key Players of Metabolic Disorder Table 9. Key Players of Others Table 10. Global Melanocortin Receptor 4 Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Melanocortin Receptor 4 Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Melanocortin Receptor 4 Market Share by Region (2021-2026) Table 13. Global Melanocortin Receptor 4 Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Melanocortin Receptor 4 Market Share by Region (2027-2032) Table 15. Melanocortin Receptor 4 Industry Trends Table 16. Melanocortin Receptor 4 Industry Drivers Table 17. Melanocortin Receptor 4 Industry Opportunities and Challenges Table 18. Melanocortin Receptor 4 Industry Restraints Table 19. Global Melanocortin Receptor 4 Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Melanocortin Receptor 4 Revenue Market Share by Company (2021-2026) Table 21. Global Melanocortin Receptor 4 Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Melanocortin Receptor 4 Key Company Head Office and Area Served Table 23. Global Melanocortin Receptor 4 Company, Product Type & Application Table 24. Global Melanocortin Receptor 4 Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Melanocortin Receptor 4 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Melanocortin Receptor 4 Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Melanocortin Receptor 4 Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Melanocortin Receptor 4 Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Melanocortin Receptor 4 Revenue Market Share by Type (2021-2026) Table 31. Global Melanocortin Receptor 4 Revenue Market Share by Type (2027-2032) Table 32. Global Melanocortin Receptor 4 Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Melanocortin Receptor 4 Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Melanocortin Receptor 4 Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Melanocortin Receptor 4 Revenue Market Share by Application (2021-2026) Table 36. Global Melanocortin Receptor 4 Revenue Market Share by Application (2027-2032) Table 37. Pfizer Inc. Company Information Table 38. Pfizer Inc. Business Overview Table 39. Pfizer Inc. Melanocortin Receptor 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Pfizer Inc. Melanocortin Receptor 4 Product Portfolio Table 41. Pfizer Inc. Recent Development Table 42. AstraZeneca Plc Company Information Table 43. AstraZeneca Plc Business Overview Table 44. AstraZeneca Plc Melanocortin Receptor 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. AstraZeneca Plc Melanocortin Receptor 4 Product Portfolio Table 46. AstraZeneca Plc Recent Development Table 47. Rhythm Pharmaceuticals, Inc. Company Information Table 48. Rhythm Pharmaceuticals, Inc. Business Overview Table 49. Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Product Portfolio Table 51. Rhythm Pharmaceuticals, Inc. Recent Development Table 52. Retrophin Inc. Company Information Table 53. Retrophin Inc. Business Overview Table 54. Retrophin Inc. Melanocortin Receptor 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Retrophin Inc. Melanocortin Receptor 4 Product Portfolio Table 56. Retrophin Inc. Recent Development Table 57. Palatin Technologies, Inc. Company Information Table 58. Palatin Technologies, Inc. Business Overview Table 59. Palatin Technologies, Inc. Melanocortin Receptor 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Palatin Technologies, Inc. Melanocortin Receptor 4 Product Portfolio Table 61. Palatin Technologies, Inc. Recent Development Table 62. Obexia AG Company Information Table 63. Obexia AG Business Overview Table 64. Obexia AG Melanocortin Receptor 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Obexia AG Melanocortin Receptor 4 Product Portfolio Table 66. Obexia AG Recent Development Table 67. Mallinckrodt Plc Company Information Table 68. Mallinckrodt Plc Business Overview Table 69. Mallinckrodt Plc Melanocortin Receptor 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Mallinckrodt Plc Melanocortin Receptor 4 Product Portfolio Table 71. Mallinckrodt Plc Recent Development Table 72. North America Melanocortin Receptor 4 Market Size by Type (2021-2026) & (US$ Million) Table 73. North America Melanocortin Receptor 4 Market Size by Type (2027-2032) & (US$ Million) Table 74. North America Melanocortin Receptor 4 Market Size by Application (2021-2026) & (US$ Million) Table 75. North America Melanocortin Receptor 4 Market Size by Application (2027-2032) & (US$ Million) Table 76. North America Melanocortin Receptor 4 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. North America Melanocortin Receptor 4 Market Size by Country (2021-2026) Table 78. North America Melanocortin Receptor 4 Market Size by Country (2027-2032) Table 79. Europe Melanocortin Receptor 4 Market Size by Type (2021-2026) & (US$ Million) Table 80. Europe Melanocortin Receptor 4 Market Size by Type (2027-2032) & (US$ Million) Table 81. Europe Melanocortin Receptor 4 Market Size by Application (2021-2026) & (US$ Million) Table 82. Europe Melanocortin Receptor 4 Market Size by Application (2027-2032) & (US$ Million) Table 83. Europe Melanocortin Receptor 4 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. Europe Melanocortin Receptor 4 Market Size by Country (2021-2026) Table 85. Europe Melanocortin Receptor 4 Market Size by Country (2027-2032) Table 86. China Melanocortin Receptor 4 Market Size by Type (2021-2026) & (US$ Million) Table 87. China Melanocortin Receptor 4 Market Size by Type (2027-2032) & (US$ Million) Table 88. China Melanocortin Receptor 4 Market Size by Application (2021-2026) & (US$ Million) Table 89. China Melanocortin Receptor 4 Market Size by Application (2027-2032) & (US$ Million) Table 90. Asia Melanocortin Receptor 4 Market Size by Type (2021-2026) & (US$ Million) Table 91. Asia Melanocortin Receptor 4 Market Size by Type (2027-2032) & (US$ Million) Table 92. Asia Melanocortin Receptor 4 Market Size by Application (2021-2026) & (US$ Million) Table 93. Asia Melanocortin Receptor 4 Market Size by Application (2027-2032) & (US$ Million) Table 94. Asia Melanocortin Receptor 4 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. Asia Melanocortin Receptor 4 Market Size by Country (2021-2026) Table 96. Asia Melanocortin Receptor 4 Market Size by Country (2027-2032) Table 97. South America, Middle East & Africa Melanocortin Receptor 4 Market Size by Type (2021-2026) & (US$ Million) Table 98. South America, Middle East & Africa Melanocortin Receptor 4 Market Size by Type (2027-2032) & (US$ Million) Table 99. South America, Middle East & Africa Melanocortin Receptor 4 Market Size by Application (2021-2026) & (US$ Million) Table 100. South America, Middle East & Africa Melanocortin Receptor 4 Market Size by Application (2027-2032) & (US$ Million) Table 101. South America, Middle East & Africa Melanocortin Receptor 4 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. South America, Middle East & Africa Melanocortin Receptor 4 Market Size by Country (2021-2026) Table 103. South America, Middle East & Africa Melanocortin Receptor 4 Market Size by Country (2027-2032) Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Melanocortin Receptor 4 Product Image Figure 2. Global Melanocortin Receptor 4 Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Melanocortin Receptor 4 Market Share by Type: 2025 VS 2032 Figure 4. Cosyntropin Image Figure 5. Corticotropin Image Figure 6. Bremelanotide Image Figure 7. Others Image Figure 8. Global Melanocortin Receptor 4 Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Melanocortin Receptor 4 Market Share by Application: 2025 VS 2032 Figure 10. Genito Urinary System Image Figure 11. Infection Disease Image Figure 12. Women's Health Image Figure 13. Metabolic Disorder Image Figure 14. Others Image Figure 15. Global Melanocortin Receptor 4 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 17. Global Melanocortin Receptor 4 Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Melanocortin Receptor 4 Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Melanocortin Receptor 4 Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Melanocortin Receptor 4 Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Melanocortin Receptor 4 Revenue Market Share by Type (2021-2032) Figure 24. Global Melanocortin Receptor 4 Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Melanocortin Receptor 4 Revenue Market Share by Application (2021-2032) Figure 26. North America Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 27. North America Melanocortin Receptor 4 Market Share by Type (2021-2032) Figure 28. North America Melanocortin Receptor 4 Market Share by Application (2021-2032) Figure 29. North America Melanocortin Receptor 4 Market Share by Country (2021-2032) Figure 30. United States Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 31. Canada Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 33. Europe Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 34. Europe Melanocortin Receptor 4 Market Share by Type (2021-2032) Figure 35. Europe Melanocortin Receptor 4 Market Share by Application (2021-2032) Figure 36. Europe Melanocortin Receptor 4 Market Share by Country (2021-2032) Figure 37. Germany Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 38. France Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 40. Italy Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 41. Russia Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 43. China Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 44. China Melanocortin Receptor 4 Market Share by Type (2021-2032) Figure 45. China Melanocortin Receptor 4 Market Share by Application (2021-2032) Figure 46. Asia Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 47. Asia Melanocortin Receptor 4 Market Share by Type (2021-2032) Figure 48. Asia Melanocortin Receptor 4 Market Share by Application (2021-2032) Figure 49. Asia Melanocortin Receptor 4 Market Share by Country (2021-2032) Figure 50. Japan Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 54. India Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 55. Australia Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Melanocortin Receptor 4 Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Melanocortin Receptor 4 Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Melanocortin Receptor 4 Market Share by Country (2021-2032) Figure 60. Brazil Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 65. UAE Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 67. Chile Melanocortin Receptor 4 Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Cosyntropin
  • Corticotropin
  • Bremelanotide
  • Others
Applications
  • Genito Urinary System
  • Infection Disease
  • Women's Health
  • Metabolic Disorder
  • Others
Companies covered
  • Pfizer Inc.
  • AstraZeneca Plc
  • Rhythm Pharmaceuticals, Inc.
  • Retrophin Inc.
  • Palatin Technologies, Inc.
  • Obexia AG
  • Mallinckrodt Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Melanocortin Receptor 4 Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Cosyntropin
  5. 1.2.3 Corticotropin
  6. 1.2.4 Bremelanotide
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Melanocortin Receptor 4 Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Genito Urinary System
  11. 1.3.3 Infection Disease
  12. 1.3.4 Women's Health
  13. 1.3.5 Metabolic Disorder
  14. 1.3.6 Others
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Melanocortin Receptor 4 Growth Trends by Region
  17. 1.5.1 Global Melanocortin Receptor 4 Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Melanocortin Receptor 4 Market Size by Region (2021-2026)
  19. 1.5.3 Melanocortin Receptor 4 Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Melanocortin Receptor 4 Market Dynamics
  1. 2.1 Melanocortin Receptor 4 Industry Trends
  2. 2.2 Melanocortin Receptor 4 Industry Drivers
  3. 2.3 Melanocortin Receptor 4 Industry Opportunities and Challenges
  4. 2.4 Melanocortin Receptor 4 Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Melanocortin Receptor 4 Revenue by Company (2021-2026)
  2. 3.2 Global Melanocortin Receptor 4 Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Melanocortin Receptor 4 Key Company Head office and Area Served
  4. 3.4 Global Melanocortin Receptor 4 Company, Product Type & Application
  5. 3.5 Global Melanocortin Receptor 4 Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Melanocortin Receptor 4 Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Melanocortin Receptor 4 Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Melanocortin Receptor 4 Tier 1, Tier 2, and Tier 3
4 Melanocortin Receptor 4 Market by Type
  1. 4.1 Global Melanocortin Receptor 4 Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Melanocortin Receptor 4 Market Size by Type (2021-2032)
  3. 4.3 Global Melanocortin Receptor 4 Market Size Share by Type (2021-2032)
5 Melanocortin Receptor 4 Market by Application
  1. 5.1 Global Melanocortin Receptor 4 Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Melanocortin Receptor 4 Market Size by Application (2021-2032)
  3. 5.3 Global Melanocortin Receptor 4 Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Pfizer Inc.
  2. 6.1.1 Pfizer Inc. Company Information
  3. 6.1.2 Pfizer Inc. Business Overview
  4. 6.1.3 Pfizer Inc. Melanocortin Receptor 4 Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Pfizer Inc. Melanocortin Receptor 4 Product Portfolio
  6. 6.1.5 Pfizer Inc. Recent Developments
  7. 6.2 AstraZeneca Plc
  8. 6.2.1 AstraZeneca Plc Company Information
  9. 6.2.2 AstraZeneca Plc Business Overview
  10. 6.2.3 AstraZeneca Plc Melanocortin Receptor 4 Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 AstraZeneca Plc Melanocortin Receptor 4 Product Portfolio
  12. 6.2.5 AstraZeneca Plc Recent Developments
  13. 6.3 Rhythm Pharmaceuticals, Inc.
  14. 6.3.1 Rhythm Pharmaceuticals, Inc. Company Information
  15. 6.3.2 Rhythm Pharmaceuticals, Inc. Business Overview
  16. 6.3.3 Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Product Portfolio
  18. 6.3.5 Rhythm Pharmaceuticals, Inc. Recent Developments
  19. 6.4 Retrophin Inc.
  20. 6.4.1 Retrophin Inc. Company Information
  21. 6.4.2 Retrophin Inc. Business Overview
  22. 6.4.3 Retrophin Inc. Melanocortin Receptor 4 Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Retrophin Inc. Melanocortin Receptor 4 Product Portfolio
  24. 6.4.5 Retrophin Inc. Recent Developments
  25. 6.5 Palatin Technologies, Inc.
  26. 6.5.1 Palatin Technologies, Inc. Company Information
  27. 6.5.2 Palatin Technologies, Inc. Business Overview
  28. 6.5.3 Palatin Technologies, Inc. Melanocortin Receptor 4 Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Palatin Technologies, Inc. Melanocortin Receptor 4 Product Portfolio
  30. 6.5.5 Palatin Technologies, Inc. Recent Developments
  31. 6.6 Obexia AG
  32. 6.6.1 Obexia AG Company Information
  33. 6.6.2 Obexia AG Business Overview
  34. 6.6.3 Obexia AG Melanocortin Receptor 4 Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Obexia AG Melanocortin Receptor 4 Product Portfolio
  36. 6.6.5 Obexia AG Recent Developments
  37. 6.7 Mallinckrodt Plc
  38. 6.7.1 Mallinckrodt Plc Company Information
  39. 6.7.2 Mallinckrodt Plc Business Overview
  40. 6.7.3 Mallinckrodt Plc Melanocortin Receptor 4 Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Mallinckrodt Plc Melanocortin Receptor 4 Product Portfolio
  42. 6.7.5 Mallinckrodt Plc Recent Developments
7 North America
  1. 7.1 North America Melanocortin Receptor 4 Market Size (2021-2032)
  2. 7.2 North America Melanocortin Receptor 4 Market Size by Type
  3. 7.2.1 North America Melanocortin Receptor 4 Market Size by Type (2021-2026)
  4. 7.2.2 North America Melanocortin Receptor 4 Market Size by Type (2027-2032)
  5. 7.2.3 North America Melanocortin Receptor 4 Market Share by Type (2021-2032)
  6. 7.3 North America Melanocortin Receptor 4 Market Size by Application
  7. 7.3.1 North America Melanocortin Receptor 4 Market Size by Application (2021-2026)
  8. 7.3.2 North America Melanocortin Receptor 4 Market Size by Application (2027-2032)
  9. 7.3.3 North America Melanocortin Receptor 4 Market Share by Application (2021-2032)
  10. 7.4 North America Melanocortin Receptor 4 Market Size by Country
  11. 7.4.1 North America Melanocortin Receptor 4 Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Melanocortin Receptor 4 Market Size by Country (2021-2026)
  13. 7.4.3 North America Melanocortin Receptor 4 Market Size by Country (2027-2032)
  14. 7.4.4 North America Melanocortin Receptor 4 Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Melanocortin Receptor 4 Market Size (2021-2032)
  2. 8.2 Europe Melanocortin Receptor 4 Market Size by Type
  3. 8.2.1 Europe Melanocortin Receptor 4 Market Size by Type (2021-2026)
  4. 8.2.2 Europe Melanocortin Receptor 4 Market Size by Type (2027-2032)
  5. 8.2.3 Europe Melanocortin Receptor 4 Market Share by Type (2021-2032)
  6. 8.3 Europe Melanocortin Receptor 4 Market Size by Application
  7. 8.3.1 Europe Melanocortin Receptor 4 Market Size by Application (2021-2026)
  8. 8.3.2 Europe Melanocortin Receptor 4 Market Size by Application (2027-2032)
  9. 8.3.3 Europe Melanocortin Receptor 4 Market Share by Application (2021-2032)
  10. 8.4 Europe Melanocortin Receptor 4 Market Size by Country
  11. 8.4.1 Europe Melanocortin Receptor 4 Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Melanocortin Receptor 4 Market Size by Country (2021-2026)
  13. 8.4.3 Europe Melanocortin Receptor 4 Market Size by Country (2027-2032)
  14. 8.4.4 Europe Melanocortin Receptor 4 Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Melanocortin Receptor 4 Market Size (2021-2032)
  2. 9.2 China Melanocortin Receptor 4 Market Size by Type
  3. 9.2.1 China Melanocortin Receptor 4 Market Size by Type (2021-2026)
  4. 9.2.2 China Melanocortin Receptor 4 Market Size by Type (2027-2032)
  5. 9.2.3 China Melanocortin Receptor 4 Market Share by Type (2021-2032)
  6. 9.3 China Melanocortin Receptor 4 Market Size by Application
  7. 9.3.1 China Melanocortin Receptor 4 Market Size by Application (2021-2026)
  8. 9.3.2 China Melanocortin Receptor 4 Market Size by Application (2027-2032)
  9. 9.3.3 China Melanocortin Receptor 4 Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Melanocortin Receptor 4 Market Size (2021-2032)
  2. 10.2 Asia Melanocortin Receptor 4 Market Size by Type
  3. 10.2.1 Asia Melanocortin Receptor 4 Market Size by Type (2021-2026)
  4. 10.2.2 Asia Melanocortin Receptor 4 Market Size by Type (2027-2032)
  5. 10.2.3 Asia Melanocortin Receptor 4 Market Share by Type (2021-2032)
  6. 10.3 Asia Melanocortin Receptor 4 Market Size by Application
  7. 10.3.1 Asia Melanocortin Receptor 4 Market Size by Application (2021-2026)
  8. 10.3.2 Asia Melanocortin Receptor 4 Market Size by Application (2027-2032)
  9. 10.3.3 Asia Melanocortin Receptor 4 Market Share by Application (2021-2032)
  10. 10.4 Asia Melanocortin Receptor 4 Market Size by Country
  11. 10.4.1 Asia Melanocortin Receptor 4 Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Melanocortin Receptor 4 Market Size by Country (2021-2026)
  13. 10.4.3 Asia Melanocortin Receptor 4 Market Size by Country (2027-2032)
  14. 10.4.4 Asia Melanocortin Receptor 4 Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Melanocortin Receptor 4 Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Melanocortin Receptor 4 Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Melanocortin Receptor 4 Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Melanocortin Receptor 4 Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Melanocortin Receptor 4 Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Melanocortin Receptor 4 Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Melanocortin Receptor 4 Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Melanocortin Receptor 4 Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Melanocortin Receptor 4 Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Melanocortin Receptor 4 Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Melanocortin Receptor 4 Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Melanocortin Receptor 4 Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Melanocortin Receptor 4 Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Melanocortin Receptor 4 Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst